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 
Abstract— A number of acoustic super-resolution techniques have 
recently been developed to visualize microvascular structure and 
flow beyond the diffraction limit. A crucial aspect of all ultrasound 
super-resolution (SR) methods using single bubble localization is 
the time-efficient detection of individual bubble signals. Due to the 
need for bubbles to circulate through the entire vasculature during 
acquisition, slow flows associated with the microcirculation limit 
the minimum acquisition time needed to obtain adequate spatial 
information. Here, a model is developed to investigate the 
combined effects of imaging parameters, bubble signal density, 
and vascular flow on SR image acquisition time. We find that the 
estimated minimum time needed for SR increases for slower blood 
velocities and greater resolution improvement. To improve from a 
resolution of /10 to /20 while imaging the microvasculature 
structure modelled here, the estimated minimum acquisition time 
increases by a factor of 14. The maximum useful image acquisition 
frame rate for an imaging depth of 5 cm is set by the bubble 
velocity at low blood flows (< 150 mm/s) and by the acoustic wave 
velocity at higher bubble velocities. Furthermore, the image 
acquisition procedure, transmit frequency, localization precision, 
and desired super-resolved image contrast together determine the 
optimal acquisition time achievable for a fixed flow velocity. 
Exploring the effects of both system parameters and details of the 
target vasculature can allow better choice of acquisition settings, 
and provide improved understanding of the completeness of SR 
information. 
 
Index Terms— Biomedical imaging, Microbubbles, 
Microvasculature, Ultrasonic imaging, Ultrasound, Resolution, 
Poisson statistics.  
 
I. INTRODUCTION 
 
on-invasive imaging of the microvasculature is 
crucial for the early detection and intervention of 
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diseases such as cancer [1], [2], ischemia [3] and 
peripheral arterial disease [4]–[6].  
Acoustic super-resolution (SR) techniques have 
recently been developed to visualize microvascular 
structure and flow beyond the diffraction limit using 
microbubble contrast agents [7]–[16]. A crucial 
aspect of all methods based on single-bubble 
localization is the detection of spatially isolated 
signals from microbubbles [17]–[19]. Obtaining 
these isolated signals may be achieved in a number 
of ways, including the use of suitable microbubble 
concentrations with contrast imaging modes and 
background subtraction techniques [7], [8], or linear 
imaging techniques with singular value 
decomposition [11], [12], differential imaging [13], 
differential imaging with spatiotemporal nonlocal 
means filtering [14] or background subtraction 
methods [9][15][20]. Furthermore, the recent use of 
nanodroplets for US-SR has the benefit of providing 
sparsely activated microbubbles without the 
requirement for sufficient blood flow [21], [22]. In 
all these cases, the number of individual microbubble 
signals detected and localized per frame is restricted 
by the diffraction limited nature of the acquired data. 
Since these methods rely upon the combined 
localization information gathered over a series of 
frames, minimizing potentially long acquisition 
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times is crucial. 
In previous work, SR has been demonstrated 
using both conventional line-by-line focused 
acquisition with frame rates at or under 50 Hz [7], 
[8], and using high frame rate plane wave imaging 
[11]–[14], [23] where an entire 2D image plane can 
be acquired with one acoustic pulse  [24]. 
Essential to the clinical translation of SR 
techniques is the ability to generate images in 
clinically viable acquisition times. This not only 
limits patient-clinician time requirements, but also 
reduces the unwanted effects of motion during long 
scan times.  
A high localization rate can be achieved by a 
combination of factors. Firstly, an increase in frame 
rate allows more frequent sampling of microbubble 
flow through the vasculature. Due to the need for 
bubbles to circulate through the entire vasculature 
during acquisition, slow flows associated with the 
microcirculation limit the minimum acquisition time 
needed to obtain adequate spatial information. This 
therefore presents a limit to the benefit increased 
frame rates can provide on the acquisition time.  
Secondly, each frame should contain a high 
number of spatially separable bubble signals. 
However, increasing the frame signal density (or 
injected microbubble concentration) does not 
necessarily increase the localization rate since 
overlapping or interfering signals should be rejected. 
In the event these are included, resulting incorrect 
localizations may be positioned outside of the vessel 
diameter, and thus are likely to degrade the final 
image. 
The optimization of signal density in SR imaging 
is crucial to time-efficient image acquisition. The 
following model has been developed based on a 
simplified Poisson statistical model which aims to 
demonstrate and investigate the combined effects of 
acquisition imaging parameters on localization rate, 
and ultimately image acquisition time.  
II. MATERIALS AND METHODS 
A. NUMBER OF  INTERROGATIONS REQUIRED 
The acquisition time required to create a super-
resolved image is given by 
 
 𝐴𝑐𝑞𝑢𝑖𝑠𝑖𝑡𝑖𝑜𝑛 𝑇𝑖𝑚𝑒 = 𝑡𝑖  ∙ 𝑁𝑖 (1) 
where 𝑡𝑖  is the time to acquire a single interrogation, 
and 𝑁𝑖 is the total number of interrogations needed 
to obtain sufficient microbubble localizations. Here, 
an interrogation is defined as the sequence of pulse-
echoes required to produce a single 2D frame or 3D 
volume. 
To estimate the number of interrogations required, 
the likelihood of imaging spatially isolated 
microbubbles is required.  Here, we image a cubic 
volume 𝑉 with sides of length 𝑙𝑥,𝑙𝑦, 𝑙𝑧, at a maximum 
depth 𝑑 = 𝑙𝑦, as illustrated in Figure 1. The 
proportion of the local volume containing blood 
vessels is the local vascular volume fraction, equal to 
𝑉𝑣, ranging from 0-100%. Using a contrast agent 
infusion, the microbubble signal density in the blood 
is assumed to be constant and equal to 𝐶𝑏.  
The PSF volume, or resolution voxel, 𝑉PSF, 
illustrated in Figure 2, can be approximated by  
 
 𝑉PSF = FWHM𝑥 FWHM𝑦 FWHM𝑧,  
 
 (2) 
Figure 1. Illustration of volume, 𝑉 imaged by the US system, where vascular 
structures occupy a sub-volume, defined by a variable local vascular volume 
fraction, 𝑉𝑣. 
where FWHM𝑥 and FWHM𝑦 are the lateral and axial 
FWHM of the PSF respectively, and FWHM𝑧 is the 
elevational resolution, or if acquiring 2D data this 
can be defined as the ‘slice thickness’, ∆𝑧. This is 
representative of the original diffraction limited 
resolution of the system. Thus, two scatterers within 
the same resolution voxel cannot be resolved. For 
simplicity, 𝑉𝑃𝑆𝐹 is represented as an isotropic voxel 
in diagrams, such that FWHM𝑥 = FWHM𝑦 =
 FWHM𝑧. In reality, the in-plane components are 
anisotropic, and these often differ greatly to the 
elevational resolution or slice thickness. 
 
 
Figure 2. The imaging volume 𝑉 can be divided in approximately PSF sized 
voxels, corresponding to the three dimensional diffraction limited resolution of 
the imaging system. 
 
If independent and discrete events occur with a 
known average rate then Poisson statistics can be 
used to express the probability of a given number, 𝑘, 
of events occurring within a fixed interval of time or 
space. In this work, an event is defined as the 
presence of a bubble, and the fixed spatiotemporal 
interval of observation is a diffraction-limited sized 
region within the imaging volume [25], [26]. It is 
assumed that bubbles do not cluster, and therefore 
bubble events can be defined for a finite set of values 
of 𝑘. Poisson statistics can thus be used to generate 
an initial distribution of bubbles from an initial 
expectation value [27]. We can then use this 
distribution to examine the probability of imaging 
single bubbles in a resolution voxel. In this case, the 
probability, 𝑃𝑃𝑆𝐹 , of having 𝑘 bubbles in a sample 
volume can be given by the following relation 
 
 
𝑃𝑃𝑆𝐹(𝑘) =  
𝜇𝑘𝑒−𝜇
𝑘!
, (3) 
 
where 𝜇 is the Poisson expectation value, given by 
the known number of events occurring in one sample 
volume, 𝑉𝑃𝑆𝐹,  
 
 𝜇 = 𝐶𝑡𝑖𝑠 ∙ 𝑉𝑃𝑆𝐹. (4) 
Here, 𝐶𝑡𝑖𝑠 is the concentration of bubbles in the local 
tissue, 
 
 𝐶𝑡𝑖𝑠 =  𝐶𝑏 ∙  𝑉𝑣 
 
(5) 
and 𝐶𝑏 is the microbubble signal density in the blood. 
Since there exists a precision associated with the 
localization of point scatterers using an US imaging 
system [7], a SR pixel, 𝐴𝑆𝑅, or voxel, 𝑉𝑆𝑅 , can be 
approximated as an area or volume with sides equal 
in length to the localization precision in the 𝑥, 𝑦 and 
𝑧 dimensions, denoted by 𝜎𝑥, 𝜎𝑦, and 𝜎𝑧 (Figure 3), 
given by 
 
 𝑉𝑆𝑅 = 𝜎𝑥𝜎𝑦𝜎𝑧. (6) 
 
The localization precision determines the FWHM of 
the Gaussian localization profile plotted for each 
localization in the final SR rendering as performed in 
our previous work in 2D [8].  
 
 
 
Figure 3. Illustration of the change of image resolution represented by a change 
in PSF voxel size, where the original resolution of the system is the PSF 
measured of the US imaging system, and the SR PSF is defined as a voxel size 
equal to the localization precision in the 𝑥, 𝑦 and 𝑧 dimensions. 
The concentration of single bubble events, 𝐶𝑆𝐵, is the 
concentration of bubbles in the tissue, multiplied by 
the probability that no bubbles fall into the same 
resolution cell, 
  
𝐶𝑆𝐵 =  𝐶𝑡𝑖𝑠𝑒
−𝐶𝑡𝑖𝑠 ∙ 𝑉𝑃𝑆𝐹 . 
 
(7) 
 
The average number of single bubble detections in a 
super-resolution voxel, 𝑛𝑆𝐵 ,  is given by  
  
𝑛𝑆𝐵 =  𝐶𝑆𝐵  ∙  𝑉𝑆𝑅. 
 
(8) 
 
The average number of localizations in a SR voxel, 
𝑁𝑙, after 𝑁𝑖 interrogations is 
  
𝑁𝑙 =  𝑁𝑖𝐶𝑆𝐵𝑉𝑆𝑅. 
 
(9) 
This value can be chosen to define the average 
number of detections per SR voxel to reach a 
sufficient signal to noise ratio (SNR).  The number 
of interrogations required can then be given by 
 
   
𝑁𝑖 =
𝑁𝑙  
 𝐶𝑆𝐵𝑉𝑆𝑅
, 
𝑁𝑖 =
𝑁𝑙  
 𝐶𝑡𝑖𝑠𝑉𝑆𝑅
e𝐶𝑡𝑖𝑠∙V𝑃𝑆𝐹 . 
 
(10) 
B. IMAGING RATE 
The imaging rate, 𝐼, can be considered as the number 
of interrogations created per second, given by 
 
𝐼 =  
1
𝑡𝑖
 
 
(11) 
During imaging, microbubbles flow through the 
vasculature at an average velocity 𝑣𝑏. For the 
microbubbles to provide new spatial information in 
each consecutive interrogation, its movement should 
exceed the magnitude of the system’s localization 
precision, 𝜎 = (𝜎𝑥, 𝜎𝑦, 𝜎𝑧). Since this is often not 
isotropic, the average localization precision over all 
directions is taken. Thus, the distance moved by a 
bubble in each interrogation, 𝑑𝑏 , should be 
 
 𝑑𝑏 ≥  avg (𝜎), (12) 
 
thus 
 𝑣𝑏 ≥  𝜎 ∙ 𝐼. (13) 
  
and the flow rate limit on the minimum useful time 
between interrogations, 𝑡𝑖𝐹𝐿 , is given by 
 
 𝑡𝑖𝐹𝐿 ≥
𝜎
𝑣𝑏
 (14) 
 
Nevertheless, bubbles with velocity below this, or 
conversely, frame rates above this rate, will still 
contribute localizations to the final image, and thus 
will enhance the final SNR.  
The fundamental limit on the imaging rate is 
determined by the time of flight and image 
acquisition procedure implemented. Using CEUS 
imaging techniques such as pulse inversion (PI) [28] 
or Contrast Pulse Sequencing (CPS) [29], a single 
line is composed of multiple pulse-echoes, 𝑁𝑝𝑢𝑙𝑠𝑒𝑠, 
of varying phase or amplitude. Multiple angle plane 
wave compounding also requires echoes from 
several directed wavefronts to generate each image. 
Thus, the minimum interrogation time, termed the 
acoustic limit, 𝑡𝑖𝐴𝐿 , can be given by  
 
 
𝑡𝑖𝐴𝐿 =
2𝑑𝑁𝑝𝑢𝑙𝑠𝑒𝑠
c
, 
(15) 
 
where 𝑐 is the speed of sound in the medium, 
assumed to be constant, and 𝑑 is the imaging depth. 
C. ACQUISITION TIME 
By combining relations from previous equations, an 
approximate overall relation can be given by 
 
𝐴𝑐𝑞𝑢𝑖𝑠𝑖𝑡𝑖𝑜𝑛 𝑇𝑖𝑚𝑒
= 𝑡𝑖 (
𝑁𝑙e
𝐶𝑡𝑖𝑠∙FWHM𝑥 FWHM𝑦FWHM𝑧
 𝐶𝑡𝑖𝑠𝜎𝑥𝜎𝑦𝜎𝑧
) 
 (16) 
or 
 
𝐴𝑐𝑞𝑢𝑖𝑠𝑖𝑡𝑖𝑜𝑛 𝑇𝑖𝑚𝑒 =  𝑡𝑖 (
𝑁𝑙  e
𝐶𝑡𝑖𝑠∙V𝑃𝑆𝐹 
 𝐶𝑡𝑖𝑠𝑉𝑆𝑅
), 
 
(17) 
 
where  
𝑡𝑖 = {
𝑡𝑖𝐹𝐿 , 𝑡𝑖𝐹𝐿 > 𝑡𝑖𝐴𝐿
𝑡𝑖𝐴𝐿, 𝑡𝑖𝐹𝐿 ≤ 𝑡𝑖𝐴𝐿
 
D. INVESTIGATIONS/ SPECIFIC MODELS:  
If not varied, parameters within models are fixed 
under conditions typical for abdominal imaging 
with:  transmit frequency, 4 MHz; depth, 5 cm; flow 
velocity, 5 mm/s; 𝑁𝑙 =  1; resolution improvement 
/30, where  is the transmit wavelength, and 
localization precision 10 m in 2D where  
𝑉PSF = FWHM𝑥 FWHM𝑦∆𝑧 and 𝐴𝑆𝑅 is used in place 
of 𝑉𝑆𝑅. The FWHM is estimated by 𝜆 2⁄ . Acquisitions 
were also modelled over a range of acquisition 
parameters, SR localization precision values, and 
bubble signal densities to explore the impact on 
acquisition time.  
 
 
Tissue Variations  
 Probability of Bubble Events: Infusion 
The probability of imaging bubble events across 
varying tissue types was determined using 
Equations (3)-(5), where the tissue blood volume 
fraction ranges between that of colangiocellular 
cancer, hepatocellular carcinoma, normal liver 
parenchyma, and other highly perfused tissue or 
macrovessels. Models were performed using a 
constant microbubble infusion, where the 
microbubble signal density in the blood, 𝐶𝑏 , is 
optimized for imaging normal liver parenchyma, 
i.e. where 𝐶𝑏 ∙ 𝑉𝑣 ∙ 𝑉𝑃𝑆𝐹 = 1.   
 
 Probability of Bubble Events: Bolus 
Injection 
The probability of imaging bubble events was 
determined as described above at various time-points 
post bolus injection. This was performed using a 
peak blood microbubble concentration optimized for 
imaging normal liver parenchyma.   
 
 Effect of Vascular Velocity 
SR acquisition times were determined using 
Equation (17), where bubble velocities, 𝑣𝑏 , were 
varied between the slow flow of the micro-
vasculature, up to fast flow in the aorta, using a 
constant microbubble infusion optimized for 
normal liver parenchyma. 
 
 Effect of Transmit Frequency 
The number of frames required to create a SR image 
with fixed abdominal parameters was modelled 
using transmit frequencies between 0.5-15 MHz.  
 
 Combined Effects on Acquisition Time 
SR acquisition times were again determined using 
Equation (17), where the combined effects of 
transmit frequency, signal density, level of 
resolution improvement, and vascular velocities 
were modelled. 
III. RESULTS 
 
 
Figure 4. Probability of imaging single bubbles within the diffraction limit 
across tissues containing varying tissue blood volume fractions (% of total 
tissue) when bubble concentration in blood is optimized for imaging the 
normal liver parenchyma (orange region). Ranges of blood volume fractions 
are also shown for regions of colangiocellular cancer (pink), hepatocellular 
carcinoma (yellow) and for blood volumes above 40% which may represent 
highly perfused tissue or macrovessels (purple). Vessels with diameter above 
/2 are assumed to have a vascular volume fraction of 100%. 
 Figure 4 shows the probability of imaging bubble 
events within the diffraction limit across varying 
tissue blood volume fractions, 𝑉𝑣. Here, the bubble 
concentration in the blood is optimized for imaging 
normal liver parenchyma (orange region) of 26% 
[30] using a constant infusion. Ranges of tissue blood 
volumes are also shown for regions of 
colangiocellular cancer (pink) and hepatocellular 
carcinoma (yellow). Blood volumes above 40% 
(purple) may represent highly perfused tissue or 
macrovessels. Vessels with diameter above /2 are at 
100% blood volume per diffraction limit. For these 
vessels, the probability of imaging individual 
bubbles at this concentration is 0.09, while the 
chance of multiple bubbles occurring within the 
diffraction limit reaches 0.88. 
Figure 5 shows the concentration of sulphur hexafluoride in the blood following 
intravenous administration of SonoVue in healthy volunteers as a bolus 0.03 
ml/kg dose (Figure 5A, blue curve). This shows the probability of imaging 
single microbubbles within the diffraction limit for various time points post-
injection (Figure 5B) demonstrated by corresponding dashed lines shown in 
Figure 5A. In this example, peak bubble concentration in blood is optimized for 
imaging cancerous tissue, i.e. for 𝑉𝑣 = 13%, between colangiocellular cancer 
(pink) and Hepatocellular Carcinoma (yellow). Ranges of blood volume 
0 5 10 15
Transmit Frequency
(MHz)
10
0
10
2
10
4
10
6
10
8
10
10
R
e
q
u
ir
e
d
 F
ra
m
e
s
(N
u
m
b
e
r 
o
f 
F
ra
m
e
s
)
Number of Required Frames
80 m
70 m
60 m
50 m
40 m
30 m
20 m
10 m
Figure 6. The number of frames required to create a SR image for a given 
localization precision, see legend. The number of frames decreases with 
increasing transmit frequency for fixed depth of 5 cm at optimum bubble 
concentration. Increasing the SR localization precision will increase the number 
of localizations required in the final image and therefore increase the number 
of frames needed. 
A B 
Figure 5A) Concentration of Sulphur hexafluoride in the blood following intravenous administration of SonoVue in healthy volunteers for 0.03 
ml/kg dose (thin blue curve), spline fit (thick blue curve), data taken from [37]. B) The probability of imaging single microbubbles within the 
diffraction limit over varying tissue tissue blood volume fractions are shown, where each curve is generated for various time points post- injection. 
Time points are shown by corresponding dashed lines in A). Here, peak bubble concentration in blood is optimized for imaging cancerous tissue, 
colangiocellular cancer (pink) and hepatocellular carcinoma (yellow). Ranges of blood volumes are also shown for regions of the normal liver 
parenchyma (orange region) and for blood volumes above 40% which may represent highly perfused tissue or macrovessels (purple). 
fractions are as shown in 
 
Figure 4. Figure 5B demonstrates the difference in potential detections using a 
bolus injection in contrast to constant infusion shown in 
 
Figure 4. In this case, the optimum probability of 
detecting isolated bubbles occurs over a range of 
tissue types during bolus circulation. The steep 
concentration increase at inflow means optimal 
signal density moves from regions of high blood 
volume to those with lower as the blood 
concentration peaks. Again, at the latter part of bolus 
circulation, signal detections in tissues of high blood 
volume are likely to surpass those in less vascular 
regions due to the bubble concentration decrease. 
The estimated number of frames required to create 
a SR image decreases with increasing transmit 
frequency (Figure 6) for a fixed depth of 5 cm, 
localization precision, and at optimum bubble 
concentration. In general, relative improvements in 
the final SR precision compared with the initial 
diffraction limited resolution ultimately determines 
the number of frames required. 
At 5 cm depth with 10 µm localization precision, 
Figure 7A shows that the effective frame rate limits 
for blood velocities ranging from the 
microvasculature (< 1 mm/s) to the aorta ( 45 cm/s) 
are restricted by the bubble velocity at low blood 
flows (< 150 mm/s), but are only restricted by the 
time-of-flight at higher flows. Therefore, the 
estimated minimum time needed for SR increases for 
slower blood velocities, and for improved resolution 
(Figure 7B). In this example, to obtain a SR of /10 
while imaging the microvasculature, the estimated 
minimum time is 56 seconds, while for /20 
improvement this increases to 13 minutes.  
Figure 8 demonstrates the acquisition time needed 
to produce SR images at a fixed depth of 5 cm with 
varying bubble signal density and resolution 
improvement when imaging vasculature of varying 
flow velocities (B), resolution improvement (C), and 
frequencies (D and E), with fixed resolution 
improvement and fixed localization precision 
respectively. The curve shown in green shows the 
same conditions and is therefore identical throughout 
Figure 8B-E using the typical abdominal imaging 
parameters. The acquisition time is shown to 
increase considerably away from the optimum 
B 
A 
Acoustic  
limit 
Flow 
limit 
Figure 7 A) Frame rate limits are defined by the bubble velocity at low blood flows, while imaging at high blood flows becomes restricted only by the 
time-of-flight. Localization precision 10 m. B) Acquisition time required to create super-resolution images for a target region at 5 cm depth with blood 
velocities ranging between the microvasculature (yellow), veins and arterioles (red), vena cava (blue), arteries (purple) and aorta (green). The graph 
demonstrates an increase in acquisition time with improvements in resolution compared to the transmit wavelength, 
 
bubble signal density, determined by the transmit 
frequency. Figure 8B and C show how the minimum 
possible acquisition time changes with blood flow 
velocity and resolution improvement respectively. 
As the frequency lowers, the optimal signal density 
range narrows, however the minimum possible time 
at the optimum concentration remains the same for 
fixed resolution improvement (Figure 8D). In 
contrast, reducing the frequency increases the 
acquisition time needed to achieve the same 
localization precision even at optimal signal density 
(Figure 8E). 
IV. DISCUSSION 
The acquisition procedure, transmit frequency, 
localization precision, bubble concentration and 
desired SR image contrast together determine the 
minimum acquisition time for a given flow velocity 
and tissue blood volume fraction. 
This model aims to provide insight into the 
relationship between imaging parameters and 
microbubble concentration on the localization rate 
and overall acquisition time of SR US imaging. 
Under the assumptions of a Poisson distribution, this 
provided estimations of ideal bubble concentrations 
for minimizing acquisition time. 
As expected, acquisition time increases with those 
parameters which tend to increase the acquisition 
time for all CEUS imaging techniques, as shown in  
Equation (15), including: increased imaging depth, 
increased number of pulses within multi-pulse CEUS 
imaging techniques, increased compounding angles, 
and a decreased speed of sound in the medium of 
interest. Imaging the microvasculature however, this 
interrogation rate becomes further limited by the 
slow flows imposing an effective frame rate limit. 
The SR component (bracketed term of Equation 
(17)) demonstrates that a higher diffraction limited 
resolution, as provided by a higher transmit 
frequency, acts to decrease the acquisition time. This 
is due to the opportunity to extract a higher number 
of spatially isolated bubble signals in each frame. 
The desired number of localizations per SR voxel, 
𝑁𝑙, relates to the SNR in the resulting image; hence 
for a factor of improvement in SNR, the acquisition 
time required will increase by the same factor. This 
relies upon the algorithm’s ability to separate 
multiple bubble events. In the event that multiple 
bubbles falling within one voxel are detected by the 
algorithm as a single detection, an incorrect 
localization position may be found. This may 
decrease the resulting SNR in the image. Thus, the 
importance of accurate signal detection and 
differentiation. 
Equation (17) also demonstrates an inverse 
relationship between imaging time and localization 
B C 
D E 
A 
Figure 8. Acquisition time needed to produce SR images at fixed depth of 5 cm 
with varying bubble signal density and resolution improvement (A). Graphs 
show time required when imaging vasculature of varying flow velocities (B), 
resolution improvement (C), and frequencies (D and E), with fixed level of 
resolution improvement (/30) and fixed localization precision (10 m) 
respectively. Resolution improvement values for (E) are /62 /31, /21, /15 
for 2, 4, 6, 8 MHz respectively. If not varied, parameters are set with transmit 
frequency: 4 MHz, depth: 5 cm, flow velocity: 5 mm/s, improvement /30 and 
localization precision: 10 m. The curve shown in green is constant throughout 
A-D and corresponds to red line in (A). Dashed line in (A) indicates the 
optimum signal density. 
error; this is due to the increased size of the Gaussian 
localization plots in the final SR image.  
The results show that the use of an optimal 
concentration is crucial in reducing acquisition 
times, and thus in ensuring clinical feasibility. It was 
shown that to obtain a SR of /10 while imaging the 
slow moving microvasculature flow at 5 cm depth, 
the acquisition time could be as low as 56 seconds. If 
SonoVueTM microbubbles are administered as an 
intravenous infusion (VueJectTM, Bracco, Milan) at a 
rate of 5 ml/min, it is estimated that with an average 
of 300 million microbubbles per ml [31], and an 
average human blood volume of 4.9 litres, 5102 
microbubbles will be introduced per millilitre per 
second. After 30 seconds, 1.5x105 bubbles/ ml will 
have been introduced, compared to an optimum 
signal density provided by the model of 
approximately 0.1-1.5 x105 signals/ml. Accounting 
for a reduction in the number of microbubbles which 
are detected during imaging due to issues such as 
dissolution, the proportion of bubbles reaching the 
target area, and the polydispersed nature of the 
microbubble population, current estimations of 
signal density appear to be in the practical range for 
clinical imaging. 
‘Dencks et al 2017 provided an exponential 
expression for the acquisition time needed for the 
localisation coverage in an image to saturate to a 
value assumed to be proportional to relative blood 
volume (rBV). The reliability of rBV estimates from 
shortened measurement times are then examined 
experimentally for a specific imaging target and 
imaging parameters (bolus scans of mouse tumours). 
Our study instead aims to develop a generalised 
model which is able to predict the required imaging 
time for US-SR from user-input imaging parameters, 
microbubble concentrations and target vasculature. 
The model aims to predict the optimal microbubble 
signal density for specific imaging conditions for 
US-SR. In order to test the example studied in 
Dencks et al 2017 using our model, imaging 
parameters and tissue targets comparable to those in 
the 2017 study (40 MHz transmit frequency, 5 m 
resolution, 50 Hz frame rate, bolus injection) are 
used. The estimated acquisition time to obtain 90% 
of the localizations required to cover vascular 
regions using our model was comparable to that to 
obtain 90% of the final vascular coverage (between 
78-139 seconds depending on the peak blood 
concentration during bolus injection, and 50-101 
seconds respectively).’ 
Signal density, the density of bubble signals 
detected in the acquisition, will vary depending on 
many details of the imaging acquisition, including 
transmit frequency, bubble population and behavior, 
bandwidth, and background noise. The 
corresponding suitable injection concentration will 
depend not only on these factors, but also aspects of 
the practical set-up, e.g. the proportion of bubbles 
reaching the target area, the disease condition, and 
administration type (bolus/infusion), so could be 
patient and disease dependent. 
Indeed, an increase in temporal resolution using 
fast plane waves should provide a higher bubble 
localization rate for a given microbubble 
concentration (if bubbles are not destroyed), and 
moreover, may improve velocity estimations due to 
more frequent sampling. Since SR imaging relies 
upon the combined contributions of many 
localizations over time, for a given microbubble 
concentration, a greater frame rate should therefore 
result in a decrease in the overall acquisition time. 
This, however, does not take into account flow, and 
therefore this justification is more relevant to 
situations in which individual signals are activated 
and deactivated. Nevertheless, the SR technique 
requires that the microbubbles sample the entire 
microvascular structure during acquisition to provide 
full spatial information. This, therefore, places a 
limit on the minimum imaging time possible for 
adequate visualization. 
In the case of fast imaging of moving bubbles, two 
competing factors are at play when thinking about 
acquisition time; these relate to blood flow velocity 
and frame rate. Firstly, in order for microbubbles to 
provide new spatial information in each frame, the 
bubbles must be moving, and their position in each 
frame should contribute additional spatial 
information to the final rendering. As such, one can 
define ‘supplementary’ information to be the 
occurrence of a bubble localization in frame 𝑛 + 1 in 
which the bubble has moved beyond the localization 
precision for the same bubble in frame 𝑛.  
Conversely, the frame rate should be high enough 
that bubble motion during multi-pulse frames does 
not drastically affect the result of coherent 
compounding. The compounding of image data 
involves sending multiple plane wave transmissions 
for each nonlinear plane wave pulse, i.e. for each 
phase inverted or amplitude modulated pulse in PI, 
AM, or PIAM transmission. Bubble movement 
between each plane wave transmission may mean the 
plane waves may not be added coherently, and could 
result in artefacts, incomplete suppression of linear 
targets, or a smearing or spreading of nonlinear 
signals in the direction of motion. It is noted that an 
axial displacement of approximately half a pulse 
wavelength during the time required to acquire a 
frame will lead to destructive interference in the 
compounding operation and as a result cause image 
degradation [32]. Higher phase coherence is required 
to avoid motion artefacts in the axial direction than 
the lateral since the spatial frequency in the axial 
direction is much higher, while in the lateral 
direction the point spread function acts as a spatial 
low-pass filter [32], [33]. Smearing due to fast 
bubble movement in compounded images may cause 
a reduction in localization accuracy. Nevertheless, 
this should not cause a problem to the final 
visualization if the bubble trajectory remains within 
the lumen of the vessel, i.e. without sharp change in 
direction during each pulse sequence. 
Results demonstrated that the optimum 
probability of detecting isolated bubbles occurs over 
a range of tissue types throughout bolus circulation. 
While this means that the optimal signal density for 
an object of interest is not constant, it provides the 
opportunity to obtain SR images over a range of 
tissue types. These results also demonstrate that there 
will be preferential times post-injection to visualize 
certain tissue types. 
Even with a constant microbubble signal density, 
the considerable variation in tissue blood volume 
fraction means that regions in the image may have a 
considerably lower probability of detecting isolated 
bubbles and therefore parts of image may not be fully 
represented. 
Furthermore, the probability of imaging isolated 
microbubbles within the diffraction limit varies with 
time after a bolus injection, where the optimum 
probability will be in areas of high tissue blood 
volume immediately after contrast arrival. After fast 
inflow, the peak probability will change to lower 
tissue blood volumes, and will slowly change back to 
higher blood volumes as the contrast agent dissolves 
and is no longer remains in  the blood stream. 
There are a number of assumptions implemented 
in this model which could lead to discrepancies 
between modelled and experimental findings. The 
model assumes an ideal SR algorithm which is able 
to correctly detect single bubbles in all cases, and 
reject those from multiple bubbles within one PSF 
sized volume. A more realistic imaging scenario 
would incorporate noise, as well as varying bubble 
signals such as ringing or interference signals created 
by clouds of bubbles; these would affect the ability 
of the algorithm to identify and accurately localize 
bubbles. A condition to account for the uneven 
spatial distribution of events could also be added in 
future models [34]. Additionally, in general, 𝑉𝑃𝑆𝐹 is 
not isotropic; the elevational resolution is typically 
much larger than in-plane resolutions in 2D, and this 
can be readily modelled by the method presented 
here. Three-dimensional results can be easily 
extrapolated from the model by setting a diffraction 
limited resolution and localization precision measure 
in the elevational direction, FWHM𝑧 and 
𝜎𝑧 respectively. 
Acquisition times longer than 10 minutes would 
currently be undesirable in a clinical setting due to 
motion effects and the use of both clinician and 
patient time. Acquiring data with a 3D probe is vital 
for future clinical application. Modelling of US-SR 
in a 3D setting is required to explore the parameters 
required to minimize this time.  
The standard clinical dose of SonoVue 
microbubbles in bolus form has been shown in 
clinical experiments to be far higher than desired for 
US-SR at its peak concentration. Instead, a slow 
infusion of the same clinical dose is preferred due to 
its lower signal density, and longer potential imaging 
time due to replenishment. The calculation of the 
required microbubble concentration prior to imaging 
based on the imaging sample volume is challenging, 
and is likely to be unfeasible in a clinical 
environment. Sustaining a suitable concentration of 
microbubble scatterers within the image volume may 
instead require development of an automatic 
feedback system that regulates the bubble 
concentration. By automatically monitoring the 
bubble density per frame during image acquisition 
according to the optimum predicted by Poisson 
statistics, the concentration information could be 
used to drive an infusion pump delivering adjustable 
microbubble infusion rates. This work could 
therefore form a basis for the development of more 
complex and realistic models for SR in the future. 
One possible approach for overcoming this 
limitation is high-density imaging. By increasing 
the density potential localizations per frame, 
shorter acquisition times could be achieved. High 
density methods which exist for optical 
microscopy, such as DAOSTORM, which fits 
multiple overlapping PSFs in an iterative manner 
by analyzing pixel clusters in the residual image 
and obtains localizations by minimizing a least-
squares criterion, and CS-STORM (Compressed 
sensing STORM), which imposes sparsity priors on 
the distribution of signal sources and localizes 
based on a convex optimization problem, can 
provide increased recall rates. Various sparsity-
based techniques have recently been adopted in the 
ultrasound field [16], [35] [36] to reduce 
acquisition times.  
The number of required frames has been shown to 
increase for a decrease in transmit frequency and for 
an increase in SR precision, so will increase the 
acquisition time for any given frame rate.  
V. CONCLUSION 
Calculations based on Poisson statistics 
demonstrate the importance of retaining an 
appropriate microbubble signal density to maintain 
viable acquisition times for clinical implementations. 
Too high and the occurrence of multiple, inseparable 
signals will limit the number of isolated signals 
detected, too low and the requirement for a large 
number of frames will mean a long acquisition time. 
This, along with the image acquisition procedure, 
transmit frequency, localization precision, and 
desired super-resolved image signal to noise ratio 
together determine the optimal acquisition time for 
SR imaging for a fixed flow velocity. Exploring the 
effects of both system parameters and details of the 
target vasculature can allow better choice of 
acquisition settings, and provide improved 
understanding of the completeness of SR 
information. 
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